Task: Answer the multiple-choice question.
Question: Which drug has a 16.311\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCOc1c(C(N)=O)cc([N+](=O)[O-])cc1[N+](=O)[O-]
[b] COc1ccc(-n2c(=O)c3ccccc3n(CC(=O)NC3CCCCC3)c2=O)cc1
[c] O=C(CSc1nc(=O)n2ccccc2n1)NCc1ccccc1Cl
Answer: c. O=C(CSc1nc(=O)n2ccccc2n1)NCc1ccccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nc(=O)n2ccccc2n1)NCc1ccccc1Cl
O=C(CSc1nc(=O)n2ccccc2n1)NCc1ccccc1Cl
N-[(2-chlorophenyl)methyl]-2-(4-oxopyrido[1,2-a][1,3,5]triazin-2-yl)sulfanylacetamide